TrialBMC cardiovascular disorders2021

The impact of vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE-A multicenter randomized controlled trial.

Hiroyuki Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.